Drug:
Reaction: PRODUCT USE IN UNAPPROVED INDICATION
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555718 |
CH |
71 | 2 |
Syncope, Hypotensive crisis, Dizziness, Bradycardia, Hypotension, Drug-genetic interaction, Product use in unapproved indication, |
||||
TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, CANDESARTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PANTOPRAZOLE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 2 | 26555980 |
CA |
||
Nephrolithiasis, Drug ineffective, Hyperhidrosis, Nausea, Off label use, Product use in unapproved indication, Sedation, Nightmare, |
||||
DICLOFENAC SODIUM, ESOMEPRAZOLE MAGNESIUM, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, CELECOXIB, MEPERIDINE HYDROCHLORIDE, OXYCODONE AND ACETAMINOPHEN, HYDROMORPHONE HYDROCHLORIDE, RIZATRIPTAN BENZOATE, MORPHINE SULFATE, ONDANSETRON HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, ATENOLOL AND CHLORTHALIDONE, DULOXETINE HYDROCHLORIDE, DULOXETINE, TOPIRAMATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ALMOTRIPTAN, ALMOTRIPTAN MALATE, ONABOTULINUMTOXINA, BOTULINUM TOXIN TYPE A, GABAPENTIN, |
||||
| 3 | 26556027 |
EU |
51 | 1 |
Drug withdrawal syndrome, Restless legs syndrome, Condition aggravated, Product use in unapproved indication, Akathisia, Nausea, Depression, Neuralgia, Suicidal ideation, Anxiety, Dysphoria, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, PRAMIPEXOLE, BISOPROLOL FUMARATE, |
||||
| 4 | 26556436 |
EU |
79 | 1 |
Capillary leak syndrome, Pancytopenia, Product use in unapproved indication, |
||||
METHOTREXATE, METHOTREXATE SODIUM, CYTARABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, AZACITIDINE, VENETOCLAX, |
||||
| 5 | 26556692 |
US |
1 | |
Product use in unapproved indication, Product administered at inappropriate site, |
||||
| 6 | 26556826 |
US |
||
Product use in unapproved indication, Therapeutic response unexpected, |
||||
CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, |
||||
| 7 | 26556847 |
US |
55 | 2 |
Diverticulitis, Product use in unapproved indication, |
||||
BELUMOSUDIL, ACYCLOVIR, FOLIC ACID, RUXOLITINIB, MELATONIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SIROLIMUS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 8 | 26557078 |
EU |
1 | |
Drug intolerance, Product use in unapproved indication, Wrong technique in product usage process, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE, |
||||
| 9 | 26557080 |
GB |
47 | 1 |
Poor quality sleep, Constipation, Insomnia, Product use in unapproved indication, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 10 | 26557158 |
CA |
60 | 1 |
Neuropathy peripheral, Cough, Dyspnoea, Asthma, Full blood count abnormal, Visual impairment, Paraesthesia, Eosinophil count increased, Product use in unapproved indication, Productive cough, Malaise, Gastrooesophageal reflux disease, Hypoaesthesia, Disease recurrence, Therapeutic product effect incomplete, Haemoptysis, Eosinophilic granulomatosis with polyangiitis, Upper respiratory tract infection, Drug dependence, Vasculitis, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, BUDESONIDE, BUDESONIDE, BUDESONIDE, RANIBIZUMAB, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, GLYCOPYRROLATE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 11 | 26557159 |
US |
22 | 2 |
Urticaria, Pruritus, Swelling, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 12 | 26557178 |
US |
71 | 1 |
Injection site haematoma, Injection site bruising, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 13 | 26557181 |
US |
2 | |
Pruritus, Urticaria, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 14 | 26557246 |
US |
29 | 2 |
Urticaria, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 15 | 26557248 |
US |
35 | 2 |
Product use in unapproved indication, |
||||
DUPILUMAB, OMALIZUMAB, |
||||
| 16 | 26557266 |
CN |
60 | 2 |
Hepatic encephalopathy, Urinary retention, Product use in unapproved indication, |
||||
METHYLPREDNISOLONE, |
||||
| 17 | 26557301 |
RS |
46 | 1 |
Drug ineffective, Product use in unapproved indication, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, CARBAMAZEPINE, OLANZAPINE, QUETIAPINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 18 | 26557390 |
US |
33 | 2 |
Paraesthesia, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 19 | 26557391 |
US |
59 | 2 |
Adjustment disorder with anxiety, Eczema, Intentional dose omission, Psoriasis, Rash, Dermatitis psoriasiform, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 20 | 26557394 |
US |
57 | 1 |
Gastrointestinal disorder, Nausea, Product use in unapproved indication, |
||||
RILZABRUTINIB, FOSTAMATINIB, |
||||
| 21 | 26557414 |
US |
28 | 2 |
Psoriasis, Dermatitis atopic, Product dose omission issue, Product use in unapproved indication, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 22 | 26557421 |
US |
69 | 1 |
Rash macular, Pruritus, Skin burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 23 | 26557443 |
US |
51 | 1 |
Urticaria, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 24 | 26557492 |
US |
63 | 2 |
Pain, Rash, Discomfort, Sleep disorder due to a general medical condition, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 25 | 26557546 |
US |
45 | 2 |
Dermatitis atopic, Rash pruritic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 26 | 26557619 |
US |
44 | 1 |
Lacrimation increased, Visual impairment, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 27 | 26557624 |
US |
21 | 2 |
Injection site dryness, Injection site rash, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 28 | 26557728 |
US |
59 | 1 |
Product use in unapproved indication, Dizziness, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 29 | 26558064 |
US |
37 | 2 |
Inflammation, Product dose omission issue, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, |
||||
| 30 | 26558112 |
US |
2 | |
Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 31 | 26558140 |
US |
2 | |
Drug hypersensitivity, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 32 | 26558155 |
75 | 2 | |
Product prescribing issue, Product use in unapproved indication, |
||||
POLYETHYLENE GLYCOL 3350, |
||||
| 33 | 26558526 |
|||
Product use in unapproved indication, Extra dose administered, |
||||
POLYETHYLENE GLYCOL 3350, |
||||
| 34 | 26558576 |
16 | 2 | |
Product use in unapproved indication, Product administered to patient of inappropriate age, Therapeutic product effective for unapproved indication, |
||||
ESTRADIOL AND LEVONORGESTREL, |
||||
| 35 | 26558792 |
CN |
77 | 2 |
Coagulopathy, Product prescribing issue, Product use in unapproved indication, |
||||
RIVAROXABAN, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, |
||||
| 36 | 26558962 |
JP |
36 | 1 |
Thrombocytopenia, Neutropenia, Anaemia, Product use in unapproved indication, |
||||
CISPLATIN, IFOSFAMIDE, ETOPOSIDE, |
||||
| 37 | 26558983 |
EU |
57 | 2 |
Optic ischaemic neuropathy, Product use in unapproved indication, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 38 | 26559083 |
GB |
53 | 1 |
Alcohol poisoning, Accidental overdose, Abdominal discomfort, Burns second degree, Cardiac murmur, Catarrh, Cerebrovascular accident, Confusional state, Drug ineffective, Depression, Dysgeusia, Fatigue, Eczema, Frequent bowel movements, Gingival pain, Haematochezia, Hypopnoea, Inappropriate schedule of product administration, Migraine, Headache, Nightmare, Off label use, Pain, Pain in extremity, Palpitations, Parosmia, Pulmonary embolism, Pyrexia, Rash, Rectal haemorrhage, Rhinitis, Somnolence, Steroid dependence, Stress, Swollen tongue, Systemic lupus erythematosus, Tinnitus, Tubulointerstitial nephritis, Vertigo, Weight decreased, Impaired quality of life, Loss of personal independence in daily activities, Impaired work ability, Medication error, Product use in unapproved indication, Intentional product use issue, |
||||
CANDESARTAN CILEXETIL, LATANOPROST, FESOTERODINE FUMARATE, BUDESONIDE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, ROSUVASTATIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, DAPAGLIFLOZIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN, HYDROCORTISONE ACETATE, HYDROCORTISONE, VEDOLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OXYCODONE, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, WARFARIN SODIUM, WARFARIN, VEDOLIZUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FUROSEMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ADALIMUMAB, INFLIXIMAB-DYYB, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, DESOXIMETASONE, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PRAVASTATIN SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RAMIPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ESOMEPRAZOLE MAGNESIUM, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE, RIVAROXABAN, METHOTREXATE, METHOTREXATE SODIUM, TAMSULOSIN HYDROCHLORIDE, FOLIC ACID, TOFACITINIB, BISOPROLOL FUMARATE, EMPAGLIFLOZIN, LANSOPRAZOLE, NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, PREGABALIN, LATANOPROST, MINERAL OIL, NAPHAZOLINE HYDROCHLORIDE, TOFACITINIB CITRATE, TETRAHYDROZOLINE HYDROCHLORIDE, CAFFEINE, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, CALCIUM CARBONATE, ANTACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, DAPAGLIFLOZIN, LATANOPROST, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, ROSUVASTATIN, ROSUVASTATIN, HYDROCORTISONE ACETATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, DESOXIMETASONE, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ADALIMUMAB, ADALIMUMAB, VEDOLIZUMAB, WARFARIN SODIUM, WARFARIN, OXYCODONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ROSUVASTATIN, |
||||
| 39 | 26559095 |
CN |
62 | |
Product use in unapproved indication, Organ failure, |
||||
ENSARTINIB, |
||||
| 40 | 26559120 |
IN |
||
Graft versus host disease, Product use in unapproved indication, |
||||
RUXOLITINIB, |
||||
| 41 | 26559233 |
US |
53 | 2 |
Product use in unapproved indication, |
||||
PEMBROLIZUMAB, |
||||
| 42 | 26559339 |
US |
38 | |
Drug intolerance, Disorientation, Dizziness, Headache, Product use in unapproved indication, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 43 | 26559727 |
US |
2 | |
Product use in unapproved indication, |
||||
SPARSENTAN, |
||||
| 44 | 26560051 |
US |
1 | |
Vision blurred, Eye irritation, Periorbital swelling, Product use in unapproved indication, |
||||
RIFAXIMIN, RIFAXIMIN, |
||||
| 45 | 26560111 |
US |
1 | |
Product use in unapproved indication, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 46 | 26560226 |
US |
51 | 2 |
Drug ineffective, Product use in unapproved indication, |
||||
DUPILUMAB, OMALIZUMAB, |
||||
| 47 | 26560229 |
US |
23 | 2 |
Rash erythematous, Pruritus, Burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 48 | 26560247 |
US |
66 | 1 |
Rash erythematous, Skin burning sensation, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 49 | 26560252 |
US |
54 | 1 |
Rash, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 50 | 26560255 |
US |
12 | 1 |
Rash erythematous, Hyperhidrosis, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 51 | 26560277 |
US |
70 | 1 |
Dry eye, Dry mouth, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 52 | 26560305 |
US |
62 | 1 |
Hospitalisation, Product use in unapproved indication, |
||||
OXYCODONE, FINASTERIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CHLORPHENIRAMINE MALEATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ALFUZOSIN HYDROCHLORIDE, ERGOCALCIFEROL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, RIVAROXABAN, |
||||
| 53 | 26560329 |
US |
36 | 1 |
Product use in unapproved indication, |
||||
SPARSENTAN, SPARSENTAN, SPARSENTAN, |
||||
| 54 | 26560343 |
US |
56 | 2 |
Dyshidrotic eczema, Pruritus, Skin irritation, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 55 | 26560373 |
US |
75 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Dry skin, Peripheral swelling, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 56 | 26560391 |
US |
29 | 2 |
Dyshidrotic eczema, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 57 | 26560413 |
US |
5 | 2 |
Pruritus, Rash erythematous, Skin burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 58 | 26560415 |
US |
52 | 1 |
Injection site pain, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 59 | 26560453 |
US |
68 | 2 |
Fall, Pelvic pain, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 60 | 26560469 |
US |
44 | 2 |
Exposure during pregnancy, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 61 | 26560549 |
US |
2 | |
Product use in unapproved indication, |
||||
SPARSENTAN, |
||||
| 62 | 26560656 |
CA |
||
Hyperhidrosis, Nausea, Nephrolithiasis, Sedation, Nightmare, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, ALMOTRIPTAN, ALMOTRIPTAN MALATE, ONABOTULINUMTOXINA, BOTULINUM TOXIN TYPE A, CELECOXIB, MEPERIDINE HYDROCHLORIDE, DICLOFENAC, DICLOFENAC SODIUM, OXYCODONE AND ACETAMINOPHEN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, GABAPENTIN, KETAMINE HYDROCHLORIDE, RIZATRIPTAN BENZOATE, MORPHINE SULFATE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, ATENOLOL AND CHLORTHALIDONE, DULOXETINE HYDROCHLORIDE, DULOXETINE, TOPIRAMATE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, |
||||
| 63 | 26560734 |
CA |
2 | 2 |
Blood creatine phosphokinase increased, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, TRAMETINIB, TRAMETINIB, |
||||
| 64 | 26560735 |
CA |
4 | 1 |
Epistaxis, Rash, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, FUROSEMIDE, FUROSEMIDE, TRAMETINIB, TRAMETINIB, |
||||
| 65 | 26560775 |
CA |
4 | 1 |
Eczema, Oedema, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, SPIRONOLACTONE, TRAMETINIB, |
||||
| 66 | 26560780 |
CA |
6 | 1 |
Dermatitis acneiform, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, FUROSEMIDE, SPIRONOLACTONE, TRAMETINIB, |
||||
| 67 | 26560783 |
CA |
||
Hyperhidrosis, Nausea, Sedation, Nephrolithiasis, Nightmare, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, ONABOTULINUMTOXINA, BOTULINUM TOXIN TYPE A, CELECOXIB, MEPERIDINE HYDROCHLORIDE, DICLOFENAC, DICLOFENAC SODIUM, OXYCODONE AND ACETAMINOPHEN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, GABAPENTIN, HYDROMORPHONE HYDROCHLORIDE, RIZATRIPTAN BENZOATE, MORPHINE SULFATE, ONDANSETRON HYDROCHLORIDE, ATENOLOL AND CHLORTHALIDONE, DULOXETINE HYDROCHLORIDE, DULOXETINE, TOPIRAMATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, ALMOTRIPTAN, ALMOTRIPTAN MALATE, |
||||
| 68 | 26560798 |
CA |
3 | 2 |
Drug eruption, Alopecia, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, TRAMETINIB, |
||||
| 69 | 26560799 |
CA |
2 | 2 |
Blood creatine phosphokinase increased, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, TRAMETINIB, |
||||
| 70 | 26560807 |
CA |
4 | 1 |
Epistaxis, Rash, Drug ineffective, Product use in unapproved indication, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, FUROSEMIDE, TRAMETINIB, |
||||
| 71 | 26560826 |
|||
Abdominal discomfort, Product use in unapproved indication, |
||||
POLYETHYLENE GLYCOL 3350, |
||||
| 72 | 26560877 |
70 | 2 | |
Vomiting, Product use in unapproved indication, Product use complaint, |
||||
POLYETHYLENE GLYCOL 3350, |
||||
| 73 | 26560908 |
US |
2 | |
Product use in unapproved indication, |
||||
SPARSENTAN, |
||||
| 74 | 26560934 |
US |
1 | |
Product use in unapproved indication, |
||||
SPARSENTAN, |
||||
| 75 | 26561042 |
US |
26 | 1 |
Product use in unapproved indication, |
||||
SPARSENTAN, SPARSENTAN, EMPAGLIFLOZIN, |
||||
| 76 | 26561077 |
US |
2 | |
Product use in unapproved indication, |
||||
SPARSENTAN, |
||||
| 77 | 26561245 |
US |
1 | |
Product use in unapproved indication, |
||||
SPARSENTAN, |
||||
| 78 | 26561248 |
GB |
2 | |
Onychomadesis, Product use in unapproved indication, |
||||
METHOTREXATE SODIUM, HYDROXOCOBALAMIN, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FOLIC ACID, |
||||
| 79 | 26561264 |
US |
1 | |
Product use in unapproved indication, |
||||
SPARSENTAN, |
||||
| 80 | 26561273 |
US |
1 | |
Product use in unapproved indication, |
||||
SPARSENTAN, |
||||
| 81 | 26561281 |
US |
2 | |
Nasopharyngitis, Product use in unapproved indication, |
||||
SPARSENTAN, |
||||
| 82 | 26561385 |
US |
2 | |
Product use in unapproved indication, Off label use, |
||||
SPARSENTAN, |
||||
| 83 | 26561491 |
EU |
24 | 2 |
Device issue, Telangiectasia, Product use in unapproved indication, |
||||
EPOPROSTENOL, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, AMBRISENTAN, TADALAFIL, |
||||
| 84 | 26550027 |
US |
29 | 2 |
Skin swelling, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 85 | 26550033 |
US |
61 | 2 |
Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 86 | 26550052 |
IN |
65 | 2 |
Encephalopathy, Toxicity to various agents, Product use in unapproved indication, |
||||
BACLOFEN, BACLOFEN, TETRABENAZINE, |
||||
| 87 | 26550094 |
US |
35 | 1 |
Brain fog, Feeling abnormal, Injection site bruising, Injection site pain, Product use in unapproved indication, |
||||
CAPLACIZUMAB, CAPLACIZUMAB, CAPLACIZUMAB, CAPLACIZUMAB, |
||||
| 88 | 26550150 |
US |
2 | |
Rash, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 89 | 26550168 |
CA |
53 | 1 |
Nephrolithiasis, Sedation, Nausea, Product use in unapproved indication, Drug ineffective, Nightmare, Off label use, Hyperhidrosis, |
||||
DICLOFENAC SODIUM, TOPIRAMATE, TOPIRAMATE SPINKLE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, ESOMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ONABOTULINUMTOXINA, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, CELECOXIB, MEPERIDINE HYDROCHLORIDE, DIHYDROERGOTAMINE MESYLATE, OXYCODONE AND ACETAMINOPHEN, GABAPENTIN, IODINE, KETAMINE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE, RIZATRIPTAN BENZOATE, MEFENAMIC ACID, MEFENAMIC ACID, MORPHINE, NORTRIPTYLINE HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, ALMOTRIPTAN, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ATENOLOL AND CHLORTHALIDONE, TOPIRAMATE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 90 | 26550236 |
US |
2 | |
Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 91 | 26550251 |
US |
1 | |
Skin swelling, Product use in unapproved indication, Dermatitis atopic, |
||||
DUPILUMAB, ALBUTEROL SULFATE, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CYANOCOBALAMIN, FENOFIBRATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HYDROCLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ONDANSETRON HYDROCHLORIDE, OXYBUTYNIN CHLORIDE, PRAMIPEXOLE, PANTOPRAZOLE SODIUM, SULFASALAZINE, TAMSULOSIN HYDROCHLORIDE, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, DULAGLUTIDE, ERGOCALCIFEROL, |
||||
| 92 | 26550266 |
CN |
59 | 2 |
Dysuria, Micturition urgency, Product use in unapproved indication, |
||||
VENETOCLAX, |
||||
| 93 | 26550325 |
US |
61 | 1 |
Product use in unapproved indication, |
||||
PEMBROLIZUMAB, |
||||
| 94 | 26550406 |
GB |
2 | |
Onychomadesis, Product use in unapproved indication, |
||||
METHOTREXATE, METHOTREXATE SODIUM, HYDROXOCOBALAMIN, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FOLIC ACID, |
||||
| 95 | 26550434 |
US |
2 | |
Exposure during pregnancy, Product use in unapproved indication, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 96 | 26550452 |
US |
74 | 1 |
Hallucination, Sedation, Movement disorder, Anxiety, Emotional distress, Product use in unapproved indication, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, DONEPEZIL HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, CLONAZEPAM, ROSUVASTATIN, VENLAFAXINE HYDROCHLORIDE, FINASTERIDE, RASAGILINE MESYLATE, RASAGILINE, SENNOSIDES, SENNA LEAF, SENNA, QUETIAPINE, METOPROLOL SUCCINATE, ERGOCALCIFEROL, |
||||
| 97 | 26550636 |
US |
56 | 2 |
Intestinal diaphragm disease, Product use in unapproved indication, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 98 | 26550645 |
TR |
63 | 2 |
Breast cancer female, Product use in unapproved indication, |
||||
UPADACITINIB, |
||||
| 99 | 26550683 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, C-reactive protein, C-reactive protein abnormal, Chest pain, Decreased appetite, Deep vein thrombosis postoperative, Drug hypersensitivity, Fatigue, Gait inability, Hypersensitivity, Hypertension, Hypertransaminasaemia, Hypoaesthesia, Infusion related reaction, Injury, Irritable bowel syndrome, Joint swelling, Leukopenia, Live birth, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lupus vulgaris, Malaise, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Osteoarthritis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Pregnancy, Pruritus, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid factor positive, Sciatica, Sinusitis, Swelling, Swollen joint count increased, Synovitis, Type 2 diabetes mellitus, Ulcer haemorrhage, Maternal exposure during pregnancy, Prescribed overdose, Product use in unapproved indication, Off label use, Product use issue, Therapy non-responder, Treatment failure, Therapeutic product effect decreased, Drug ineffective, Therapeutic response decreased, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, CALCIUM GLUCONATE, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, PREGABALIN, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NEOMYCIN OINTMENT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, CERTOLIZUMAB PEGOL, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, MAGNESIUM, MAGNESIUM, ERGOCALCIFEROL, RAMIPRIL, SULFASALAZINE, PIROXICAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LORAZEPAM, LISINOPRIL, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LANSOPRAZOLE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ERGOCALCIFEROL, CYANOCOBALAMIN, FISH OIL, CAFFEINE, LORAZEPAM, |
||||
| 100 | 26551238 |
US |
23 | 2 |
Illness, Product use in unapproved indication, |
||||
CAPLACIZUMAB, CAPLACIZUMAB, CAPLACIZUMAB, CAPLACIZUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28